Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of STAU1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of STAU1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of STAU1 mRNA | decreases expression | 19150397
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of STAU1 mRNA | decreases expression | 16709241
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of STAU1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of STAU1 mRNA | increases expression | 18301758
|
C010327 |
salinomycin |
salinomycin results in decreased expression of STAU1 mRNA | decreases expression | 19682730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.41 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.48 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
4.02 | 15504547 17963324 16511603 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.63 | 15136595 18608205 19217205 16595493 18357371 16110121 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
2.63 | 19682730 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.19 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.82 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
2.11 | 17971768 17045692 18930000 16799960 17088986 16332177 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.14 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.56 | 17066447 16757204 18986760 16280240 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.79 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.93 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.27 | 18772588 17172411 17016597 17287894 17018589 16340194 16510598 17169374 15001691 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 18802399 16524972 15289873 18949393 16331619 18288408 14970324 16391804 18509181 17255274 17401013 18448328 17454858 16282729 17695437 20501625 15148649 17594712 16303861 17016601 18383874 17094418 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.45 | 15095906 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.25 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
2.70 | 21346803 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.73 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.73 | 17638652 16337965 15173087 16481741 16785472 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.09 | 20131406 19236843 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.97 | 16145905 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.59 | 18337622 15162350 15102660 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 18467677 19772884 16221962 19176532 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
3.57 | 16985049 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
4.86 | 15113037 16603448 18383874 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.86 | 20007298 16377806 15890375 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.01 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.25 | 15086387 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
3.95 | 19682730 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.87 | 18986760 16757204 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.44 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.44 | 17405874 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.64 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.40 | 14694615 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.75 | 16929163 19003803 15113037 16500647 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.36 | 19082440 18626508 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.30 | 18722050 15538739 16160472 18286688 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 17522103 18567086 16424979 19015929 15786421 17172411 17498489 16951190 19084572 18396642 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.29 | 16280240 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.18 | 16803524 |